Skip to main content
Wolfson Institute of Preventive Medicine - Barts and The London

Access to chemoprevention drugs in the NHS

Centre for Cancer Prevention

Funding Body:  Cancer Research UK

Principal Investigator:  Dr Sam Smith


Use of medications, such as tamoxifen and aspirin, to reduce the risk of cancer is low among eligible patients. Uptake in chemoprevention trials is higher than initiation rates observed in clinical settings. This project will use data from a large nationally representative survey of 1000 GPs to identify potential barriers to prescribing chemoprevention in the NHS.


Dr Sam Smith
Tel:  +44 (0)20 7882 5698